SWTX:NSD-SpringWorks Therapeutics Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 32.28

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.60M

Analyst Target

USD 54.40
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-29 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
VRTX Vertex Pharmaceuticals Inc

N/A

USD 121.60B
REGN Regeneron Pharmaceuticals Inc

N/A

USD 92.70B
ARGX argenx NV ADR

N/A

USD 35.89B
ALNY Alnylam Pharmaceuticals Inc

N/A

USD 30.38B
BGNE BeiGene Ltd

N/A

USD 22.85B
MRNA Moderna Inc

N/A

USD 21.00B
UTHR United Therapeutics Corporatio..

N/A

USD 16.70B
RPRX Royalty Pharma Plc

N/A

USD 15.14B
INCY Incyte Corporation

N/A

USD 14.67B
SMMT Summit Therapeutics PLC

N/A

USD 13.75B

ETFs Containing SWTX

HFIN:CA Hamilton Enhanced Canadia.. 9.95 % 0.00 %

N/A

CAD 0.17B
CDEF:CA Manulife Smart Defensive .. 2.59 % 0.00 %

N/A

CAD 1.40M
TLV:CA Invesco S&P/TSX Composite.. 2.20 % 0.34 %

N/A

CAD 0.08B
XMD:CA iShares S&P/TSX Completio.. 1.87 % 0.61 %

N/A

CAD 0.23B
CEW:CA iShares Equal Weight Banc.. 0.00 % 0.60 %

N/A

CAD 0.23B
DXM:CA 0.00 % 0.67 %

N/A

N/A
FLI:CA CI U.S. & Canada Lifeco C.. 0.00 % 0.92 %

N/A

CAD 0.09B
HEF:CA 0.00 % 0.83 %

N/A

N/A
HPR:CA Global X Active Preferred.. 0.00 % 0.63 %

N/A

CAD 1.00B
PR:CA Lysander-Slater Preferred.. 0.00 % 1.03 %

N/A

CAD 0.08B
RODM Hartford Multifactor Deve.. 0.00 % 0.31 %

N/A

N/A
BANK:CA Evolve Canadian Banks and.. 0.00 % 0.39 %

N/A

CAD 0.28B
BNC:CA Purpose Canadian Financia.. 0.00 % 0.68 %

N/A

N/A
TQCD:CA TD Q Canadian Dividend ET.. 0.00 % 0.00 %

N/A

CAD 0.38B
FICS First Trust International.. 0.00 % 0.00 %

N/A

USD 0.15B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -11.56% 35% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.56% 35% F 33% F
Trailing 12 Months  
Capital Gain 39.62% 49% F 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.62% 49% F 71% C-
Trailing 5 Years  
Capital Gain 74.20% 59% D- 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 74.20% 59% D- 73% C
Average Annual (5 Year Horizon)  
Capital Gain 26.87% N/A N/A 82% B
Dividend Return 26.87% N/A N/A 82% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 77.05% N/A N/A 23% F
Risk Adjusted Return 34.87% N/A N/A 67% D+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector